Status:
NOT_YET_RECRUITING
Berbevis Dose-finding Study in Subjects With Impaired Fasting Glucose
Lead Sponsor:
Azienda di Servizi alla Persona di Pavia
Conditions:
Impaired Fasting Glucose (IFG)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Assessing the effects of a nutraceutical supplement (Berbevis™) in adults with impaired fasting glucose (100-126 mg/dL) and BMI between 25 and 35. Ninety participants will be assigned to three paralle...
Eligibility Criteria
Inclusion
- fasting blood glucose between 100 and 126 mg/dl
- BMI between 25 and 35 kg/m\^2
Exclusion
- Fasting blood glucose below 100 mg/dl
- BMI \< 25 or \> 35 kg/m\^2
Key Trial Info
Start Date :
June 15 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06955234
Start Date
June 15 2026
End Date
September 15 2026
Last Update
November 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.